TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats

European Journal of Pharmacology

Volumn 343, Issue 2-3, 1998, Pages 129-133

  Kinoshita, Kiyoshi ^a   Watanabe, Yumi ^a   Yamamura, Michio ^a   Matsuoka, Yuzo ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

3 Acetylpyridine; Anti ataxic effect; NMDA receptor; TA 0910; TRH (thyrotropin releasing hormone)

Indexed keywords

3 ACETYLPYRIDINE; BACLOFEN; BICUCULLINE; CYPROHEPTADINE; DIZOCILPINE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINAMIDE; PRAZOSIN; PROTIRELIN; PROTIRELIN DERIVATIVE; PROTIRELIN RECEPTOR; TALTIRELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBELLAR ATAXIA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; JUMPING; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CEREBELLAR ATAXIA; MALE; MOTOR ACTIVITY; NIACINAMIDE; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, THYROTROPIN-RELEASING HORMONE; THYROTROPIN-RELEASING HORMONE;

EID: 0032545949     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01539-2     Document Type: Article

References (21)

1. Breese G.R., Cott J.M., Cooper B.R., Prange A.J., Lipton M.A., Plotnikoff N.P. Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. J. Pharm. Exp. Ther. 193:1975;11-22.
2. Chishima S. A radioimmunoassay for TA-0910, a new metabolically stable thyrotropin-releasing hormone analogue. Pharm. Biomed. Anal. 12:1994;795-804.
3. Denk H., Haider M., Kovac W., Studynka G. Behavioral changes and neuropathological feature in rats intoxicated with 3-acetylpyridine. Acta Neuropathol. 10:1968;34-44.
4. Desclin J.C., Escubi J. Effects of 3-acetylpyridine on the central nervous system of the rat, as demonstrated by silver method. Brain Res. 77:1974;349-364.
5. Deutch A.Y., Rosin D.L., Goldstein M., Roth R.H. 3-Acetylpyridine-induced degeneration of the nigrostriatal dopamine system: An animal model of olivopontocerebellar atrophy-associated Parkinsonism. Exp. Neurol. 105:1989;1-9.
6. Griffiths E.C. Clinical applications of thyrotropin-releasing hormone. Clin. Sci. 73:1986;449-457.
7. Horita A., Carino M.A., Lai H. Pharmacology of thyrotropin-releasing hormone. Ann. Rev. Pharmacol. Toxicol. 26:1986;311-332.
8. Kasparov S., Pawelzik H., Zieglgansberger W. Thyrotropin-releasing hormone enhances excitatory postsynaptic potentials in neocortical neurons of the rat in vivo. Brain Res. 656:1994;229-235.
9. Kinoshita K., Nagao T., Ono H. Effects of TA-0910, an orally active TRH analog, on the spinal reflex in spinal rats. Neuropharmacology. 33:1994;1183-1188.
10. Kinoshita K., Fujitsuka T., Yamamura T., Matsuoka Y. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals. Eur. J. Pharmacol. 274:1995;65-72.
11. Kinoshita K., Watanabe Y., Asai H., Yamamura M., Matsuoka Y. Anti-ataxic effects of TRH and its analogue, TA-0910, in rolling mouse Nagoya by metabolic normalization of the central tegmental area. Br. J. Pharmacol. 116:1995;3274-3278.
12. Koeppen, A.H., Barron, K.D., 1984. The neuropathology of olivopontocerebellar atrophy. In: R.C. Duvoisin, A. Plaitakis (Eds.), The Olivopontocerebellar Atrophies. Raven Press, New York, pp. 13-38.
13. Llinas R., Walton K., Hillman D.E. Inferior olive: Its role in motor learning. Science. 190:1975;1230-1231.
14. Moriyasu M., Nasu M., Honda H., Sakamoto T., Yamamura M., Matsuoka Y. Effect of (-)-N-[(S)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinylcarbonyl]-L-histidyl-L- of TSH and thyroid hormones in rats. Folia Pharmacol. Jpn. 107:1996;285-297.
15. O'Leary R., O'Connor B. Thyrotropin-releasing hormone. J. Neurochem. 65:1995;953-963.
16. Pitts L.H., Ross A., Chase G.A., Faden A.I. Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cords injuries. J. Neurotrauma. 12:1995;235-243.
17. Sharif N.A. Diverse roles of thyrotropin-releasing hormone in brain, pituitary and spinal function. Trends Pharmacol. Sci. 6:1985;119-122.
18. Sobue I., Matsuoka, Y., Katoh, K., Sakuma, A., 1986. TRH therapy of ataxia in patients with SCD. In: I. Sobue (Ed.), TRH and Spinocerebellar Degeneration. Elsevier, Amsterdam, pp. 173-188.
19. Stocca G., Nistri A. Enhancement of NMDA receptor mediated synaptic potentials of rat hippocampal neurons in vitro by thyrotropin releasing hormone. Neurosci. Lett. 184:1995;9-12.
20. Watanabe Y., Kinoshita K., Koguchi A., Yamamura M. A new method for evaluation of motor deficits in 3-acetylpyridine-treated rats. J. Neurosci. Methods. 77:1997;25-29.
21. Yamamura M., Kinoshita K., Nakagawa H., Tanaka T., Maeda K., Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (1): Effects on the central nervous system by oral administration. Jpn. J. Pharmacol. 53:1990;451-461.